HSD52: A Non-Coding RNA Molecule with Potential Applications in Drug Development and Personal Medicine

Target Name: HSD52

NCBI ID: G729467

HSD52

Other Name(s): uncharacterized LOC729467 | Uncharacterized LOC729467

HSD52: A Non-Coding RNA Molecule with Potential Applications in Drug Development and Personal Medicine

HSD52, also known as U571828, is a non-coding RNA molecule that has been shown to play a critical role in the regulation of gene expression in various organisms, including humans. Its function as a drug target or biomarker makes it an attractive target for researchers to investigate, and its potential applications in drug development and personalized medicine have gained significant attention in recent years.

HSD52 is a small non-coding RNA molecule that is typically expressed in a highly conserved region of the genome. It is composed of 72 amino acid residues and has a molecular weight of approximately 8 kDa. HSD52 is primarily localized to the cytoplasm of the cell and is associated with various cellular processes, including cell adhesion, migration, and the regulation of gene expression.

One of the most significant functions of HSD52 is its ability to interact with the protein p21 (TNFAIP3), a transcription factor that plays a critical role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation. HSD52 has been shown to physically interact with p21 and can also enhance the transcriptional activity of p21. This interaction between HSD52 and p21 has been shown to play a role in the regulation of various cellular processes, including the regulation of cell proliferation and the control of cell death.

In addition to its interaction with p21, HSD52 has also been shown to play a role in the regulation of gene expression in various organisms. For example, studies have shown that HSD52 can physically interact with the protein Myr1 (MYRNA1) and enhance its transcriptional activity. This interaction between HSD52 and Myr1 has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and cell signaling.

HSD52 has also been shown to play a role in the regulation of cellular signaling pathways that are involved in various cellular processes, including cell adhesion, migration, and the regulation of cell death. For example, studies have shown that HSD52 can physically interact with the protein ZEB2 (Zeb2) and enhance its transcriptional activity. This interaction between HSD52 and ZEB2 has been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and the regulation of cell death.

In addition to its role in the regulation of gene expression, HSD52 has also been shown to have potential as a drug target or biomarker. For example, studies have shown that HSD52 can be highly targeted by small molecules and can be used as a lead compound for the development of new drugs. Additionally, HSD52 has been shown to have a relatively high safety profile, which makes it an attractive target for biomarker development.

HSD52 has also been shown to play a role in the regulation of cellular processes that are involved in the development and progression of various diseases, including cancer. For example, studies have shown that HSD52 can be highly expressed in various types of cancer and can be used as a potential biomarker for the diagnosis and prognosis of these diseases.

In conclusion, HSD52 is a non-coding RNA molecule that has been shown to play a critical role in the regulation of gene expression in various organisms. Its interaction with the protein p21 and its ability to enhance the transcriptional activity of p21 have been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and cell signaling. Additionally, HSD52 has also been shown to play a role in the regulation of gene expression in various organisms and has potential as a drug target or biomarker. Further research is needed to fully understand the role of HSD52 in

Protein Name: Uncharacterized LOC729467

The "HSD52 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HSD52 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets